Gemox
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer (NCT05156788) | Shanghai Zhongshan Hospital | 2021-12-12 |
Track Gemox automatically
Every clearance here is in the API, with alerts when new ones post.